The latest price target for HealthEquity (NASDAQ:HQY) was reported by Barrington Research on September 4, 2024. The analyst firm set a price target for $105.00 expecting HQY to rise to within 12 months (a possible 32.59% upside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by Barrington Research, and HealthEquity maintained their outperform rating.

The last upgrade for HealthEquity Inc happened on September 21, 2023 when Baird raised their price target to $87. Baird previously had a neutral for HealthEquity Inc.

The last downgrade for HealthEquity Inc happened on December 7, 2021 when Raymond James changed their price target from $90 to $70 for HealthEquity Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on September 4, 2024 so you should expect the next rating to be made available sometime around September 4, 2025.

While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $105.00 to $105.00. The current price HealthEquity (HQY) is trading at is $79.19, which is out of the analyst’s predicted range.